South Korea Chondroitin glucosamine capsule

2021-08-24 11:36:30

Dallas, the State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, in collaboration with Beijing Chaoyang Hospital and the University of Queensland, Australia, based on the demand for exosomes derived from regulatory T cells (Treg) increased Vascular Endothelial Growth Factor (Vascular Endothelial Growth Factor, VEGF) antibody, through a new scope model and a new anti-mechanism, significantly inhibited the progress of fundus renewal.

The formation of fundus neoplasia is an important disease in the course of many fundus diseases such as age-related macular degeneration and extensive clinical diabetes. However, there are still the problems of excessive tearing of drugs with the room water, enrichment of fundus lesions by massage, and limited group treatment strategies. Engineering process, the State Key Laboratory of Biochemistry of the Institute of Process Engineering, based on ground-based Treg-derived exosomes (rEXS) and clinically existing VEGF drug-resistant drugs, proposed new strategies for "spatial and temporal supplementary drugs" and "anti-VEGF-new adjuvant therapy" , And cooperated with Beijing Chaoyang Hospital and University of Queensland erythema to report new discoveries in the treatment of new fundus neonatal sudden diseases.

Product recommendation: Korean Chondroitin Glucosamine Capsules

Indications:

1. Antioxidants (natural antioxidants)

2. Prevent arthritis and relieve nervous system inflammation

3. Immune regulation

4. Anti-virus and parasitic infection (anti-herpes virus 1 (HSV-1) infection/antiprotozoal infection)

5. Regenerative medicine (repair the central nervous system, liver regeneration)

Note: The above content is for introduction only, and the medication must be carried out under the guidance of a doctor in a regular hospital.